Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ruinno Medical is a Shanghai-based medical technology company dedicated to the development of advanced minimally invasive surgical robotic systems. Founded in 2017 by industry veterans with experience at Intuitive Surgical, the company focuses on creating high-precision robotic platforms that rival international standards. Its flagship multi-arm laparoscopic surgical robot has received NMPA approval, targeting applications in urology, gynecology, thoracic, and general surgery. Ruinno aims to increase the accessibility of robotic surgery in China through domestic innovation and cost-effective manufacturing. The company is supported by a strong syndicate of investors, including Legend Capital and Qiming Venture Partners, positioning it as a significant player in the domestic surgical robotics market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rui Nuo Medical Technology.